Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T48598 | Target Info | |||
Target Name | GTPase KRas (KRAS) | ||||
Synonyms | c-Ki-ras; c-K-ras; RASK2; Ki-Ras; KRAS2; K-Ras 2 | ||||
Target Type | Clinical trial Target | ||||
Gene Name | KRAS | ||||
Biochemical Class | Small GTPase | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | Mecysteine | Ligand Info | |||
Canonical SMILES | COC(=O)C(CS)N | ||||
InChI | 1S/C4H9NO2S/c1-7-4(6)3(5)2-8/h3,8H,2,5H2,1H3/t3-/m0/s1 | ||||
InChIKey | MCYHPZGUONZRGO-VKHMYHEASA-N | ||||
PubChem Compound ID | 29145 |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 5TAR Crystal structure of farnesylated and methylated kras4b in complex with PDE-delta (crystal form II - with ordered hypervariable region) | ||||||
Method | X-ray diffraction | Resolution | 1.90 Å | Mutation | No | [1] |
PDB Sequence |
GTEYKLVVVG
10 AGGVGKSALT20 IQLIQNHFVD30 EYDPTIEDSY40 RKQVVIDGET50 CLLDILDTAG 60 QEEYSAMRDQ70 YMRTGEGFLC80 VFAINNTKSF90 EDIHHYREQI100 KRVKDSEDVP 110 MVLVGNKCDL120 PSRTVDTKQA130 QDLARSYGIP140 FIETSAKTRQ150 GVDDAFYTLV 160 REIRKHKEKM170 SKDGKKKKKK180 SKTK
|
|||||
|
||||||
PDB ID: 5TB5 Crystal structure of full-length farnesylated and methylated KRAS4b in complex with PDE-delta (crystal form I - with partially disordered hypervariable region) | ||||||
Method | X-ray diffraction | Resolution | 2.00 Å | Mutation | No | [1] |
PDB Sequence |
GTEYKLVVVG
10 AGGVGKSALT20 IQLIQNHFDS39 YRKQVVIDGE49 TCLLDILDTA59 GQEEYSAMRD 69 QYMRTGEGFL79 CVFAINNTKS89 FEDIHHYREQ99 IKRVKDSEDV109 PMVLVGNKCD 119 LPSRTVDTKQ129 AQDLARSYGI139 PFIETSAKTR149 QGVDDAFYTL159 VREIRKHKEK 169 MSKDKKKKSK182 TK
|
|||||
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Structural basis of recognition of farnesylated and methylated KRAS4b by PDE-Delta. Proc Natl Acad Sci U S A. 2016 Nov 1;113(44):E6766-E6775. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.